drugset / Trial / NCT00735449

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects

NCT00735449

Phase 4 Completed 204 enrolled Allergan
RandomizedParallel-groupSingle-blindTreatment

Summary

Efficacy and safety evaluation of Combigan with timolol when each is used as adjunctive therapy to Xalatan in subjects with glaucoma or ocular hypertension.

Timeline

Start
2008-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule 0.2 %
Comparator Timolol Other / unclassified 0.5 %
Comparator Latanoprost Small molecule 0.005 %